Skip to main content

Navigation group

Type at least 3 characters
1,511 articles

Articles

Original Research

Published on 10 Aug 2022

Comparison of real-world data (RWD) analysis on efficacy and post-progression outcomes with pembrolizumab plus chemo vs chemo alone in metastatic non-squamous non-small cell lung cancer with PD-L1 < 50%

in Thoracic Oncology

  • Ilaria Attili
  • Carmine Valenza
  • Celeste Santoro
  • Gabriele Antonarelli
  • Pamela Trillo Aliaga
  • Ester Del Signore
  • Chiara Catania
  • Gianluca Spitaleri
  • Antonio Passaro
  • Filippo de Marinis
Comparison of real-world data (RWD) analysis on efficacy and post-progression outcomes with pembrolizumab plus chemo vs chemo alone in metastatic non-squamous non-small cell lung cancer with PD-L1 < 50%
Frontiers in Oncology
doi 10.3389/fonc.2022.980765
  • 3,386 views
  • 6 citations